New opportunities for nanoparticles in cancer immunotherapy
Abstract Background Recently, cancer immunotherapy has become standard for cancer treatment. Immunotherapy not only treats primary tumors, but also prevents metastasis and recurrence, representing a major advantage over conventional cancer treatments. However, existing cancer immunotherapies have li...
Main Authors: | Wooram Park, Young-Jae Heo, Dong Keun Han |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association for the Advancement of Science (AAAS)
2018-09-01
|
Series: | Biomaterials Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40824-018-0133-y |
Similar Items
-
Stimuli-Responsive Polymeric Nanomaterials for the Delivery of Immunotherapy Moieties: Antigens, Adjuvants and Agonists
by: Raveena Nagareddy, et al.
Published: (2021-11-01) -
Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
by: Abigail Cheever, et al.
Published: (2022-11-01) -
miR-aculous new avenues for cancer immunotherapy
by: William W. Tang, et al.
Published: (2022-09-01) -
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
by: Muyue Yang, et al.
Published: (2021-07-01) -
The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and Progression
by: Vanessa G. P. Souza, et al.
Published: (2023-12-01)